Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine Augmentation of Clozapine in Treatment-Refractory Schizophrenia
NCT00216281Phase 3Terminated
- Sponsor
- Indiana University School of Medicine
- Start
- Sep 2005
- Primary completion
- Oct 2006
- Countries
- 1
01
Overview
A Phase 3 trial of atomoxetine in schizophrenia, sponsored by Indiana University School of Medicine. Started Sep 2005; status: terminated.
02
Drugs
atomoxetine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00216281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216281.